Delray Beach, FL – Evolve Exchange, a provider of cloud-based software to EMR vendors, has announced that Remedi Software and Systems has completed integration using their TwinLink Specialty White Label EMR. Following the integration, Remedi Software completed their 2014 CERHT process and is now among several other EMR vendors who have attained MU2 certification via a white label solution from Evolve Exchange. As an Ophthalmology EMR vendor, Evolve Exchange and the TwinLink Specialty White Label solution were a perfect fit for Remedi Software. “Evolve Exchange has provided a solution for Remedi Software & Systems to bring a certified and proprietary Ophthalmic software package to the market much quicker than we had originally projected” states George Lucas, CEO of Remedi Software & Systems. “With the utilization of the certified Evolve Exchange TwinLink white label solution we are in the market at a substantial savings in R&D and certification costs. Evolve Exchange has proven to be a highly professional and excellent business partner.” TwinLink is specifically designed for specialty EMR vendors and their providers to meet meaningful use stage 2 certification. This integration allows for providers to continue using the original vendor software and launch the Evolve Exchange Certified EMR via a button within the application. Once the application is open, the MU Data Set is entered to achieve Meaningful Use Stage 2 Certification. A seamless integration allows for data synchronization between applications and Evolve Exchange will also suggest subtle UI workflow connections to maximize efficiency. By choosing this innovative solution from Evolve Exchange, Remedi has saved research and development resources, streamlined their certification process and empowered their providers to meet Meaningful Use attestation deadlines. About Evolve Exchange Evolve Exchange has developed a secure Medical Cloud Infrastructure that empowers EMR Companies to meet 2014 CERHT requirements. By combining a secure platform that integrates seamlessly with existing EMR applications, a powerful suite of MU2 business services and a flexible pricing model, Evolve Exchange enables EMR vendors and their providers to meet Meaningful Use Stage 2 objectives. View PDF Press Release
Meaningful Use Stage 2 is a huge undertaking for most EMR vendors. The recent CMS proposed rule has provided vendors with one last chance to get their software ready for attestation while confirming what we all know- MU2 and future certifications are here to stay. Below we outline 3 reasons why you shouldn’t delay in getting your EMR MU2 certified.1. Don’t be a victim of CMS unpredictability.
Instead, our solutions will help you become an early adopter so you don’t have to worry about penalties, delays and your customers’ “hardship” exemptions.2. The “delay” is not as long as it seems.
Make no mistake, attestation will begin in January of 2015 without any further delays. This short time frame, coupled with the sheer complexity of MU2, means that your MU2 development should be nearing completion.3. You’ve been given a life-line, don’t waste it!
There’s no denying that MU2 is a huge mountain to climb. That’s why CMS has given EMR vendors a little extra time to get their software up to speed. Utilize this time as it was intended- to get your EMR software certified and ready for future meaningful use certifications.To learn about our solutions call 888.218.9522
The economics of digital medical records has thus far been unfair to doctors. It has been assumed that since doctors are responsible for the medical chart they should pay the cost for the technology. But in an era when patient information data is exchanged to the benefit of stakeholders including the Government, the Insurance Carriers, and the Patients themselves this onerous expense should no longer be solely the responsibility of the doctors- the status quo is unfair.
Government subsidies to doctors in the form of incentive payments for using Meaningful Use Electronic Medical Software have only partially reimbursed doctors for bearing this cost. And, of course, there will be the ongoing cost of hardware and software upgrades, the cost of maintaining the system, the cost of data entry, and the cost of data security over the Internet per HIPAA and Hi-tech. In an era of decreasing reimbursement and margins, doctors are expected to bear this expense cheerfully. I propose an Electronic Security Charge of $1 per visit per patient so that patients bear part of the burden of cost for the security of their data on the Internet.Dr. Mark Freeman
1. Easily Attain Meaningful Use Stage 2 Certification Simply sign a few documents and make a nominal payment to the certifying body to receive your MU2 certification and your very own listing on the ONC certified product list website. Avoid testing and save nearly $20,000! 2. Save on costly research and development We’ve already done the heavy lifting. Our AstralJet EMR is built on a secure medical cloud infrastructure and has successfully met all of the challenging MU2 criteria including Transitions of Care, CQM Submissions and AMC Calculations. We will also be adding additional functionality including mobile app and voice navigation. 3. Avoid the “Hardship Exemption” embarrassment Notifying your doctor customers that they’ll need to apply for a hardship exemption is just plain embarrassing. Instead, be a Hero by providing a state-of-the-art MU2 certified EMR with a beautifully designed interface and cutting-edge functionality. Schedule a Demo Today by Calling 888.218.9522 or email email@example.com
Despite some recent backpedaling on the Meaningful Use Stage 2 Timetable by the ONC, those in the know continue to operate on the principle that the Federal Government will not back off on their long term policy goal of achieving a Nationwide Health Information Network.
In 2014, this agenda has collided with the adoption of ICD10 and the difficulties of adapting to the Affordable Care Act, so it has become necessary for the Feds to temporize the Meaningful Use Stage 2 Timetable to give the smaller EMR Vendors and their Doctor Customers some breathing room. For this reason, the ONC recently announced that Doctors using EMR Vendors that have not yet achieved Meaningful Use Stage 2 will be exempted from the Medicare Payment Penalty, which is based upon 2014 performance and is due to take effect in 2015. However, these Doctors will not receive 2015 Incentive Dollars since they will not be able to attest to Meaningful Use Stage 2 in 2014.
For a small EMR Vendor to achieve Meaningful Use Stage 2 on any timetable is a giant challenge, considering the complexities that must be solved. If these EMR Vendors determine that they lack the resources to get this done, they face a difficult dilemma. Their choices boil down to hunkering down with their present Doctor Customers or selling their assets since new adopters and those switching their EMR will not choose an MU 1 Only Vendor. However, there is the possibility that these EMR Vendors could White Label an EMR/PM that is already Meaningful Use Stage 2. This would, on an immediate basis and without these EMR Vendors having to take the Certification Test, empower these Companies with MU2, allowing their Doctor Customers to attest to MU2 in calendar year 2014. For a specialty EMR, this would involve an alignment of their Application with the White Label MU2 Certified EMR where the Common Meaningful Use Data Set would be entered. Furthermore, these EMR Vendors could at the same time get off the R & D Merry-Go-Round and devote their efforts to marketing and sales since presumably the Company from whom they White Label would keep pace with the future stages of Meaningful Use.
If such a White Label scenario were considered, migration of the EMR Vendor Company’s data for all their Doctor Customers would be necessary. And whether the EMR Vendor had a Client/Server Platform or a Cloud Platform, they would be faced with the question of what kind of Platform was used by the MU 2 White Label Partner Company.
This is important because the delivery of Software to the UI is now quickly evolving to the Cloud Platform so that an EMR Vendor choosing a White Label Partner would not want to make the mistake of looking backward by choosing a Client/Server Partner. Specifically, this choice would directly impact the migration of the data and whether this critical process was accomplished without exceeding a threshold of error so that their Doctor Customers remained satisfied.
Migration consists of 3 parts:
-Access the old data
-Transform the data
-Store the new data
If the data stored in a Client/Server Platform System is migrated to a Cloud Platform, there are many locations converging on one location, the Cloud. The advantages here are that migration steps 2 and 3 are done by the Cloud Company, the migration to the Cloud does not finish unless the migration is correct, any subtle errors found later only have to be fixed in the Cloud (one and done), and all Updates are done in the Cloud (one and done). Migrating to a Client/Server Platform involves work in every Doctor Customer’s Office. If there are 200 Doctor Customers involved, then 200 separate transitions must take place to accomplish the entire migration, and each one of these separate 200 transitions involves Local IT Workers, which increases the chances for error. If there is an error, all 200 offices will have to be fixed individually. Furthermore, when you get to the Go-Live Starting Point, the Software is not necessarily the same in all 200 offices- there is the possibility for varied sets of complications that are unique to one or more sites, resulting in several troubleshooting excavations with specific and discrete results. And, of course, all Updates have to be done 200 times- done in every office.
Migration is not the only reason an EMR Vendor in the market to White Label a MU 2 certified product would want to choose a partner with a Cloud Platform. Per above, the EMR Vendor would be relying on their Partner to attain MU 3, MU4, and MU 5, and these future certifications can best be accomplished with a Cloud Platform. In fact, a Client/Server Platform will increasingly be under pressure to apply makeshift solutions to pass the measures in these future certifications. Another reason to choose a Cloud Platform is that the Interoperability that is the chief goal of the entire Federal Enterprise will ultimately only be possible with a Cloud Platform when all upstream complexities have been fully worked out and have flowed downstream. From that perspective, we have only begun to understand completely and utilize efficiently the possibilities that the Cloud Platform can unlock, for like the human brain itself it undoubtedly contains vast dimensions that are yet to be discovered and harnessed for the good of industry.
If Interoperability is the chief goal of the EMR Evolution, then Meaningful Use 2 is a big step in the right direction. The Direct Project and the Patient Portal open the door to a new world of medical information communication. Since more information in the hands of the Doctor at the point of care translates into more accurate diagnosis and treatment (on a statistical basis), Interoperability will improve outcomes and prevent a quantum of adverse events. The corollary of this is that Interoperability must be efficient in terms of ease of use and speed of transaction. Anything else will render useless our large investment in HIT Interoperability. This, of course, assumes that the Patient Data being communicated is accurate since inaccurate Patient Data will perpetuate past errors and end up doing harm. So it is vitally important that Doctors enter accurate Patient Data into the System, for in this new era of Electronic Data every data point entered is being published through the System. Now as to the frenzy being generated by the expectancy that great efficiencies/advancements will come from the computerization of Medicine, let me supply a dose of reality. Contrary to current thinking, documentation of medical data and events in the patient’s chart – whether the chart is electronic or paper – has absolutely nothing to do with the quality of medicine being practiced, except that the chart must document accurately the patient’s essential data so that the Doctor can review that data as he is seeing the patient. Documentation is only documentation and aside from the important previous statement it has no bearing on the patient’s outcome. Furthermore, the present investment in Analytics (big data) will not prove to be of any value – it will go down as an enormous waste of time and dollars. The computer generated analysis of trillions of medical data points will either mislead us or merely tell us things that present knowledge and experience have already told us.
Press Release :
Evolve Exchange, a South Florida based Health Technology Company, today announced that its AstralJet v4.1 EMR has been certified as a Complete Ambulatory 2014 Meaningful Use Stage 2 Certified EMR by Drummond Group. Evolve Exchange took their EMR through the process of certification to prove the quality, effectiveness, and strength of its core Medical Cloud infrastructure. Evolve Exchange’s Medical Cloud Infrastructure is designed to enable Interoperability and empower EMR Companies to become Meaningful Use Stage 2 Certified by partnering with them. “Achieving Meaningful Use Stage 2 Certification is a difficult undertaking, even for the most technically skilled EMR Companies,” stated Mark Freeman MD, Evolve Exchange’s CEO. “We understand the challenges EMR Companies are facing as they navigate the 2014 MU 2 process. We invite EMR Companies to partner with us so that we can help them to achieve MU 2.” Evolve Exchange has established partnerships with third party providers for e-Prescribing, e-Labs, PM Clearinghouse, Mini-PACS, Voice Command Navigation, CQM Submissions & AMC Calculations, Mobile App Functionality, and Health Vault Patient Portal. Their solution allows a client application to take advantage of their bleeding edge Cloud Infrastructure. Evolve Exchange’s Network enables a gateway providing the mapping and coding needed to generate the signed C-CDA messages for compliance with the Interoperability Measures for Meaningful Use Stage 2 Certification.About Evolve Exchange, Inc. Evolve Exchange has developed a secure Medical Cloud Infrastructure that empowers EMR Companies to achieve MU 2. Our mission is to accelerate Interoperability between EMR Companies, Health Information Exchanges, and Third Party Medical Facilities through our powerful Medical Cloud Network Infrastructure. Evolve Exchange will provide you with the essential tools and services needed to achieve MU 2. For more information about Evolve Exchange visit them at HIMSS14, booth 8345 or contact: Seth Golbe, VP of Sales and Development, 888-218-9522 or firstname.lastname@example.org. About Drummond Group Inc. Drummond Group Inc. is a global software test and certification lab that serves a wide range of vertical industries. In healthcare, Drummond Group tests and certifies Controlled Substance Ordering Systems (CSOS), Electronic Prescription of Controlled Substances (EPCS) software and processes, and Electronic Health Records (EHRs) – designating the trusted test lab as the only third-party certifier of all three initiatives designed to move the industry toward a digital future. Founded in 1999, and accredited for the Office of the National Coordinator HIT Certification Program as an Authorized Certification Body (ACB) and an Accredited Test Lab (ATL), Drummond Group continues to build upon its deep experience and expertise necessary to deliver reliable and cost-effective services. For more information, please visit http://www.drummondgroup.com or email DGI@drummondgroup.com. This Complete Ambulatory EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments. Evolve Exchange, Inc. AstralJet v4.1 Date Certified: 2/13/14 Certification ID#: 02132014-2112-1 Modules Tested: 170.314(a)(1‐15); 170.314(b)(1‐5, 7) 170.314(c)(1‐3); 170.314(d)(1‐8); 170.314(e)(1‐3); 170.314(f)(1‐3); 170.314(g)(2‐4) Clinical Quality Measures Tested: CMS068v3; CMS069v2; CMS122v2; CMS126v2; CMS138v2; CMS147v2; CMS154v2; CMS163v2; CMS165v2 Additional software used: DrFirst Rcopia, Microsoft HealthVault